Abstract
Haemovigilance (HV) plays an essential role in ensuring the safety of donors and recipients with regard to blood transfusions. China now has annually survey on blood collection and supply, but no national reporting system of AR/AE related to blood transfusion. By 2013, the first guideline on HV in China was released by the Blood Quality Management Committee of Chinese Society of Blood Transfusion (CSBT) and revised in 2015. For blood establishments and hospitals looking for help with setting up new plans or further improving blood transfusion safety, the guideline provides ample information on definitions, methodology and documentation protocols. Based on the guideline, a series of education and promoting programmes was developed in Shanghai and other regions. With the integration of HV into the existing expert symposiums and education courses in the past few years, hundreds and thousands of clinicians and blood bank practitioners got training and the importance of HV were recognized widely, and the principles of nonpunitive principle and learning from errors. In 2017, the working party on haemovigilance of CSBT was set up, which is a milestone for the progress of HV in China. Through the working party, we can study the practices of antecedence countries and learning their experiences, by formulating policies, evaluating modes and mechanisms, compiling standards and guidelines, improving information management and standardization from one region to the other, to establish a national HV systems step by step in China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.